Market Place
Sourcing Support
Soleno Therapeutics Announces FDA Review Extension for DCCR Tablets
26 Nov 2024 //
GLOBENEWSWIRE
Soleno Presents Diazoxide Choline in Prader-Willi Syndrome
14 Nov 2024 //
GLOBENEWSWIRE
Soleno Therapeutics Announces DCCR Regulatory Update
08 Oct 2024 //
GLOBENEWSWIRE
Soleno Therapeutics To Present At Cantor Healthcare Conference
16 Sep 2024 //
GLOBENEWSWIRE
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Rule
19 Aug 2024 //
GLOBENEWSWIRE
Soleno Submits New Drug Application To FDA For DCCR To Treat Willi Syndrome
28 Jun 2024 //
GLOBENEWSWIRE
Soleno Announces DCCR Prader-Willi Data At ENDO 2024
22 May 2024 //
GLOBENEWSWIRE
Soleno`s DCCR Gets FDA Breakthrough Designation in PWS
29 Apr 2024 //
GLOBENEWSWIRE
Soleno Presents Positive Long-Term Data for Prader-Willi Syndrome Treatment
15 Jun 2022 //
TRIALSITENEWS
Soleno Provides Regulatory Update on DCCR for Prader-Willi Syndrome
24 Jan 2022 //
GLOBENEWSWIRE
Soleno Announces Positive Data Showing Improvements in Symptoms of PWS
08 Sep 2021 //
GLOBENEWSWIRE
Soleno Announces Late-Breaking Oral Presentation with Body Composition Results
29 Oct 2020 //
GLOBENEWSWIRE
Updated data from Soleno`s DCCR late-stage study shows positive outcome
30 Sep 2020 //
SEEKING ALPHA
Novitium Pharma`s Generic Diazoxide Receives Approval in US
15 Jul 2020 //
FDA
e5 Pharma`s Generic Diazoxide Receives Approval in US
20 Dec 2019 //
FDA
e5 Pharma Launches First FDA Approved Generic For Proglycem®
20 Dec 2019 //
PR NEWSWIRE
Iranians Fear Medicine Shortages as U.S. Tightens Sanctions
12 Nov 2018 //
NYTIMES
Iranians Fear Medicine Shortages as U.S. Tightens Sanctions
12 Nov 2018 //
NYTIMES
SoCal Essentialis and Bay Area Biotech to Merge and Form Newly Combined Company
27 Dec 2016 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.